Cargando…
Development and validation of a yeast high-throughput screen for inhibitors of Aβ(42) oligomerization
Recent reports point to small soluble oligomers, rather than insoluble fibrils, of amyloid β (Aβ), as the primary toxic species in Alzheimer’s disease. Previously, we developed a low-throughput assay in yeast that is capable of detecting small Aβ(42) oligomer formation. Specifically, Aβ(42) fused to...
Autores principales: | Park, Sei-Kyoung, Pegan, Scott D., Mesecar, Andrew D., Jungbauer, Lisa M., LaDu, Mary Jo, Liebman, Susan W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3209651/ https://www.ncbi.nlm.nih.gov/pubmed/21810907 http://dx.doi.org/10.1242/dmm.007963 |
Ejemplares similares
-
Inhibition of Aβ(42) oligomerization in yeast by a PICALM
ortholog and certain FDA approved drugs
por: Park, Sei-Kyoung, et al.
Publicado: (2016) -
Endocytic pathways mediating oligomeric Aβ42 neurotoxicity
por: Yu, Chunjiang, et al.
Publicado: (2010) -
Modulation of Aβ(42 )low-n oligomerization using a novel yeast reporter system
por: Bagriantsev, Sviatoslav, et al.
Publicado: (2006) -
Introducing Human APOE into Aβ Transgenic Mouse Models
por: Tai, Leon M., et al.
Publicado: (2011) -
TDP-43 Toxicity in Yeast Is Associated with a Reduction in Autophagy, and Deletions of TIP41 and PBP1 Counteract These Effects
por: Park, Sei-Kyoung, et al.
Publicado: (2022)